Neurocrine Biosciences to present at Bank of America Health Care Conference on May 12, 2026

Neurocrine Biosciences announced its executives will present at the Bank of America Health Care Conference on May 12, 2026, in Las Vegas. The presentation will be webcast live and available for replay on the company's website. Neurocrine is a biopharmaceutical company focused on developing treatments for neurological, endocrine, psychiatric, and immunological disorders, with several FDA-approved drugs and a strong pipeline. This event offers investors insight into the company's progress and future plans.